Agios Pharmaceuticals
AGIO
AGIO
167 hedge funds and large institutions have $2.37B invested in Agios Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 84 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.34% less ownership
Funds ownership: 97.02% → 95.68% (-1.3%)
38% less call options, than puts
Call options by funds: $11.1M | Put options by funds: $17.9M
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
167
Holding in Top 10
4
Calls
$11.1M
Puts
$17.9M
Top Buyers
| 1 | +$46.1M | |
| 2 | +$44M | |
| 3 | +$34.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.8M |
| 5 |
BlackRock
New York
|
+$26.2M |
Top Sellers
| 1 | -$56.4M | |
| 2 | -$11.4M | |
| 3 | -$7.93M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$7.3M |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
-$5.15M |